- €195.98m
- €222.09m
- €245.88m
- 92
- 57
- 53
- 78
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 232 | 239 | 214 | 225 | 246 |
Cost of Revenue | |||||
Gross Profit | 230 | 237 | 212 | 224 | 244 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 224 | 229 | 206 | 214 | 230 |
Operating Profit | 8.01 | 9.7 | 7.45 | 11.7 | 16.2 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 5.08 | 8 | 5.02 | 9.03 | 11.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | 3.06 | 4.67 | 0.173 | 5.3 | 7.69 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 3.06 | 4.67 | 0.173 | 5.3 | 7.69 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 3.05 | 4.67 | 0.173 | 5.3 | 7.69 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.27 | 1.52 | -0.001 | 1.39 | 2.44 |
Dividends per Share |